Iridex to Participate in Fireside Chat with Stifel Equity Research

December 6, 2022

https://www.globenewswire.com/news-release/2022/12/06/2568833/0/en/Iridex-to-Participate-in-Fireside-Chat-with-Stifel-Equity-Research.html

MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ:IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in a fireside chat with its covering equity research analyst from Stifel.

Read more at globenewswire.com

Related news for (IRIX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.